CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.
As we mark World Alzheimer’s Day, it is worth reflecting on the progress made in recent years.
The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.
Approval may validate the science, but it does not secure commercial success. That outcome is determined by the decisions made before launch.
Leela Barham looks at the discussion on non-submissions to the HTA body NICE, informed by the latest metrics for VPAG.
Editor's Picks
